Justin A. Zivin
#153,881
Most Influential Person Now
Justin A. Zivin's AcademicInfluence.com Rankings
Justin A. Zivinphilosophy Degrees
Philosophy
#8623
World Rank
#12036
Historical Rank
Logic
#5652
World Rank
#7067
Historical Rank
Justin A. Zivinbiology Degrees
Biology
#11705
World Rank
#15124
Historical Rank
Neuroscience
#1921
World Rank
#1977
Historical Rank
Download Badge
Philosophy Biology
Justin A. Zivin's Degrees
- Masters Medicine University of California, San Francisco
- PhD Neuroscience University of California, San Diego
Why Is Justin A. Zivin Influential?
(Suggest an Edit or Addition)Justin A. Zivin's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- High-dose atorvastatin after stroke or transient ischemic attack. (2006) (1547)
- Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke (1992) (993)
- Tissue plasminogen activator reduces neurological damage after cerebral embolism. (1985) (386)
- NXY-059 for acute ischemic stroke. (2006) (366)
- Efficacy of site-independent telemedicine in the STRokE DOC trial: a randomised, blinded, prospective study (2008) (356)
- Metalloproteinase Inhibition Reduces Thrombolytic (Tissue Plasminogen Activator)–Induced Hemorrhage After Thromboembolic Stroke (2000) (344)
- Effects of Intense Low-Density Lipoprotein Cholesterol Reduction in Patients With Stroke or Transient Ischemic Attack: The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial (2007) (329)
- Infrared Laser Therapy for Ischemic Stroke: A New Treatment Strategy: Results of the NeuroThera Effectiveness and Safety Trial–1 (NEST-1) (2007) (319)
- Underlying structure of the National Institutes of Health Stroke Scale: results of a factor analysis. NINDS tPA Stroke Trial Investigators. (1999) (294)
- How to analyze binding, enzyme and uptake data: the simplest case, a single phase. (1982) (271)
- Atorvastatin Reduces the Risk of Cardiovascular Events in Patients With Carotid Atherosclerosis: A Secondary Analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial (2008) (256)
- Neuroprotection for ischemic stroke: Two decades of success and failure (2011) (254)
- Glutamate antagonist therapy reduces neurologic deficits produced by focal central nervous system ischemia. (1988) (251)
- Detection of arterial emboli using Doppler ultrasound in rabbits. (1991) (244)
- Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study (2008) (243)
- Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial by Stroke Subtypes (2009) (229)
- Reduction of central nervous system ischemic injury by monoclonal antibody to intercellular adhesion molecule. (1991) (223)
- Statistics for disinterested scientists. (1976) (218)
- Central and Peripheral Adrenergic Mechanisms in the Development of Deoxycorticosterone‐Saline Hypertension in Rats (1975) (218)
- Effectiveness and Safety of Transcranial Laser Therapy for Acute Ischemic Stroke (2009) (216)
- Monoclonal Antibody to the ICAM-1 Adhesion Site Reduces Neurological Damage in a Rabbit Cerebral Embolism Stroke Model (1993) (212)
- Reduction of central nervous system ischemic injury in rabbits using leukocyte adhesion antibody treatment. (1991) (208)
- Design and Baseline Characteristics of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study (2003) (203)
- Spinal Cord Infarction: A Highly Reproducible Stroke Model (1980) (203)
- Monoclonal antibodies preventing leukocyte activation reduce experimental neurologic injury and enhance efficacy of thrombolytic therapy (1995) (195)
- Transcranial Infrared Laser Therapy Improves Clinical Rating Scores After Embolic Strokes in Rabbits (2004) (186)
- Neuropathology of Experimental Spinal Cord Ischemia in the Rabbit (1982) (176)
- DISTRIBUTION OF BIOGENIC AMINES AND RELATED ENZYMES IN THE RAT PITUITARY GLAND (1975) (165)
- Assembly of Proteins to Postsynaptic Densities after Transient Cerebral Ischemia (1998) (164)
- Tissue plasminogen activator. Reduction of neurologic damage after experimental embolic stroke. (1988) (153)
- Quantitative localization of biogenic amines in the spinal cord (1975) (144)
- Hypertension in acute ischemic strokes. Not to treat. (1985) (144)
- Factors determining the therapeutic window for stroke (1998) (143)
- Changes in the Activity of Protein Kinase C and the Differential Subcellular Redistribution of Its Isozymes in the Rat Striatum During and Following Transient Forebrain Ischemia (1991) (140)
- Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. (2011) (130)
- Intravascular Cooling in the Treatment of Stroke (ICTuS): early clinical experience. (2005) (129)
- Transcranial near-infrared light therapy improves motor function following embolic strokes in rabbits: An extended therapeutic window study using continuous and pulse frequency delivery modes (2007) (127)
- Statin Treatment and Stroke Outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial (2009) (127)
- Prospective reliability of the STRokE DOC Wireless/Site Independent Telemedicine System (2005) (122)
- Reasons why few patients with acute stroke receive tissue plasminogen activator. (2006) (121)
- A novel approach to screening for new neuroprotective compounds for the treatment of stroke (2007) (121)
- Neuroprotective Effects of the Spin Trap Agent Disodium-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-Oxide (Generic NXY-059) in a Rabbit Small Clot Embolic Stroke Model: Combination Studies With the Thrombolytic Tissue Plasminogen Activator (2002) (118)
- Modification of Postsynaptic Densities after Transient Cerebral Ischemia: A Quantitative and Three-Dimensional Ultrastructural Study (1999) (114)
- Spectrum of neurological deficits in experimental CNS ischemia. A quantitative study. (1982) (110)
- Microplasmin: A Novel Thrombolytic That Improves Behavioral Outcome After Embolic Strokes in Rabbits (2002) (109)
- Dehydroepiandrosterone sulfate is neuroprotective in a reversible spinal cord ischemia model: possible involvement of GABA(A) receptors. (2000) (107)
- The effect of endocrinological manipulations on tyrosine hydroxylase and dopamine-beta-hydroxylase activities in individual hypothalamic nuclei of the adult male rat. (1974) (106)
- Baicalein, an antioxidant 12/15-lipoxygenase inhibitor improves clinical rating scores following multiple infarct embolic strokes (2007) (104)
- ACCESS: acute cerebrovascular care in emergency stroke systems. (2010) (104)
- Protein kinase C is translocated to cell membranes during cerebral ischemia (1990) (101)
- Persistent phosphorylation of cyclic amp responsive element-binding protein and activating transcription factor-2 transcription factors following transient cerebral ischemia in rat brain (1999) (99)
- Intracranial hemorrhage after coronary thrombolysis with tissue plasminogen activator. (1992) (98)
- Animal stroke models. They are relevant to human disease. (1990) (93)
- Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. (2009) (91)
- Effects of the Spin Trap Agent Disodium- [tert-butylimino)methyl]benzene-1,3-disulfonate N-Oxide (Generic NXY-059) on Intracerebral Hemorrhage in a Rabbit Large Clot Embolic Stroke Model: Combination Studies With Tissue Plasminogen Activator (2002) (90)
- Thrombolysis with tissue plasminogen activator alters adhesion molecule expression in the ischemic rat brain. (1999) (88)
- Tissue plasminogen activator‐mediated thrombolysis of cerebral emboli and its effect on hemorrhagic infarction in rabbits (1989) (87)
- Coronary Heart Disease Risk in Patients With Stroke or Transient Ischemic Attack and No Known Coronary Heart Disease: Findings From the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial (2010) (80)
- Ebselen, a Seleno-Organic Antioxidant, Is Neuroprotective After Embolic Strokes in Rabbits: Synergism With Low-Dose Tissue Plasminogen Activator (2003) (80)
- Tissue plasminogen activator plus glutamate antagonist improves outcome after embolic stroke. (1991) (80)
- Hemorrhagic transformation after cerebral ischemia: mechanisms and incidence. (1993) (79)
- Neuroprotection for ischemic stroke: Two decades of success and failure (2004) (79)
- Quantal Bioassay and Stroke (1992) (78)
- Transcranial Laser Therapy in Acute Stroke Treatment: Results of Neurothera Effectiveness and Safety Trial 3, a Phase III Clinical End Point Device Trial (2014) (76)
- Naloxone in experimental spinal cord ischemia: dose-response studies. (1984) (75)
- Catecholamines in the raphe nuclei of the rat (1976) (75)
- A model for quantitative evaluation of embolic stroke therapy (1987) (72)
- Relative and Cumulative Effects of Lipid and Blood Pressure Control in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Trial (2009) (71)
- A Long‐Half‐life and Fibrin‐Specific Form of Tissue Plasminogen Activator in Rabbit Models of Embolic Stroke and Peripheral Bleeding (1994) (71)
- Editorial commentary (2005) (70)
- Comparison of Tenecteplase with Alteplase on clinical rating scores following small clot embolic strokes in rabbits (2004) (69)
- Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack (2009) (69)
- Pharmacological Effects of the Spin Trap Agents N-t-Butyl-Phenylnitrone (PBN) and 2,2,6,6-Tetramethylpiperidine-N-Oxyl (TEMPO) in a Rabbit Thromboembolic Stroke Model: Combination Studies With the Thrombolytic Tissue Plasminogen Activator (2001) (68)
- Incidence of cerebral hemorrhage after treatment with tissue plasminogen activator or streptokinase following embolic stroke in rabbits [corrected]. (1990) (68)
- Acute Hypertension, but Not Thrombolysis, Increases the Incidence and Severity of Hemorrhagic Transformation Following Experimental Stroke in Rabbits (1996) (67)
- Safety Profile of Transcranial Near-Infrared Laser Therapy Administered in Combination With Thrombolytic Therapy to Embolized Rabbits (2008) (63)
- Changes in Expression of the DNA Repair Protein Complex DNA-Dependent Protein Kinase after Ischemia and Reperfusion (1999) (62)
- Magnetic resonance imaging in acute stroke (1998) (61)
- Graded Bioassay for Demonstration of Brain Rescue From Experimental Acute Ischemia in Rats (1994) (61)
- The nyctohemeral rhythm of plasma prolactin: effects of ganglionectomy, pinealectomy, constant light, constant darkness or 6-OH-dopamine administration. (1975) (61)
- The Evolution of Transcranial Laser Therapy for Acute Ischemic Stroke, Including a Pooled Analysis of NEST-1 and NEST-2 (2010) (61)
- Atherogenic Dyslipidemia and Residual Cardiovascular Risk in Statin-Treated Patients (2014) (60)
- Thrombolytic stroke therapy (1999) (58)
- Transcranial Laser Therapy for Acute Ischemic Stroke: A Pooled Analysis of NEST-1 and NEST-2 (2013) (58)
- Reduction of Neurological Damage by a Peptide Segment of the Amyloid β/A4 Protein Precursor in a Rabbit Spinal Cord Ischemia Model (1994) (58)
- Acute Hypertension Promotes Hemorrhagic Transformation in a Rabbit Embolic Stroke Model: Effect of Labetalol (1998) (56)
- Additional Outcomes and Subgroup Analyses of NXY-059 for Acute Ischemic Stroke in the SAINT I Trial (2006) (55)
- Tyrosine hydroxylase and dopamine-β-hydroxylase: distribution in discrete areas of the rat limbic system (1976) (52)
- Comparison of TNK With Wild-Type Tissue Plasminogen Activator in a Rabbit Embolic Stroke Model (2001) (52)
- An automated colorimetric method for the measurement of 3-hydroxybutyrate concentration. (1973) (52)
- Quantitative effects of cerebral infarction on spatial learning in rats (1992) (50)
- Coadministration of NXY-059 and tenecteplase six hours following embolic strokes in rabbits improves clinical rating scores (2004) (50)
- Neuropeptides in spinal cord injury: Comparative experimental models (1983) (49)
- Diaspirin Cross‐linked Hemoglobin Improves Neurological Outcome Following Reversible but Not Irreversible CNS Ischemia in Rabbits (1994) (47)
- Cerebral hemorrhagic risk of aspirin or heparin therapy with thrombolytic treatment in rabbits. (1991) (47)
- Neuroprotection by the Selective Cyclooxygenase-2 Inhibitor SC-236 Results in Improvements in Behavioral Deficits Induced by Reversible Spinal Cord Ischemia (2001) (47)
- The lipophilic multifunctional antioxidant edaravone (radicut) improves behavior following embolic strokes in rabbits: A combination therapy study with tissue plasminogen activator (2009) (46)
- Adult nonhepatic hyperammonemia: a case report and differential diagnosis. (2010) (44)
- Effects of calcium channel blockers on neurologic outcome after focal ischemia in rabbits. (1988) (42)
- Atorvastatin in stroke: a review of SPARCL and subgroup analysis (2010) (42)
- Empirical characteristics of litigation involving tissue plasminogen activator and ischemic stroke. (2008) (41)
- The Nonpeptide Glycoprotein IIb/IIIa Platelet Receptor Antagonist SM-20302 Reduces Tissue Plasminogen Activator–Induced Intracerebral Hemorrhage After Thromboembolic Stroke (2002) (40)
- Delayed Therapy of Experimental Ischemia With Competitive N‐Methyl‐D‐Aspartate Antagonists in Rabbits (1993) (39)
- Optimized thrombolysis of cerebral clots with tissue-type plasminogen activator in a rabbit model of embolic stroke. (1993) (38)
- Intracerebral hemorrhage after experimental embolic infarction. Anticoagulation. (1987) (37)
- Review of tissue plasminogen activator, ischemic stroke, and potential legal issues. (2008) (37)
- Effect of protein kinase C modulation on outcome of experimental CNS ischemia (1991) (37)
- Protein phosphorylation during ischemia. (1990) (35)
- Tissue Plasminogen Activator Cerebrovascular Thrombolysis in Rabbits Is Dependent on the Rate and Route of Administration (1992) (34)
- Treatment with conotoxin, an ‘N-type’ calcium channel blocker, in neuronal hypoxic-ischemic injury (1990) (33)
- Effect of ischemic cerebral volume changes on behavior (1997) (32)
- Effect of Cerebral Ischemia on Calcium/Calmodulin-Dependent Protein Kinase II Activity and Phosphorylation (1995) (32)
- The STRokE DOC Trial Technique: ‘Video Clip, Drip, and/or Ship’ (2007) (31)
- Effect of High-Dose Atorvastatin on Renal Function in Subjects With Stroke or Transient Ischemic Attack in the SPARCL Trial (2014) (31)
- The effect of two anesthetic agents on norepinephrine and dopamine in discrete brain nuclei, fiber tracts, and terminal regions of the rat (1976) (29)
- Catecholamine neurotransmitters and synthetic enzymes in the spinal cord of the rat. (1975) (29)
- 414 – Ischemic Cerebrovascular Disease (2012) (29)
- Halothane, fentanyl/nitrous oxide, and spinal lidocaine protect against spinal cord injury in the rat. (1989) (29)
- Understanding clinical trials. (2000) (29)
- Pharmacologic studies of the neuroprotective actions of a glutamate antagonist in ischemia. (1991) (28)
- Antileukocyte adhesion therapy (1997) (28)
- A stable preparation for rat brain perfusion: effect of flow rate on glucose uptake. (1972) (28)
- Glucose and D(-)-3-hydroxybutyrate uptake by isolated perfused rat brain. (1972) (25)
- Emerging Therapies for Acute Ischemic Stroke (2007) (25)
- Phenothiazines reduce ischemic damage to the central nervous system (1989) (24)
- A precise and sensitive method for measurement of spinal cord blood flow (1983) (23)
- Pharmacology of caffeinol in embolized rabbits: clinical rating scores and intracerebral hemorrhage incidence (2004) (23)
- Intraspinal glutamic decar☐ylase distribution after transection of the cord at the thoracic level (1976) (22)
- Efficacy of LY233053, a competitive glutamate antagonist, in experimental central nervous system ischemia. (1992) (22)
- Activation of nuclear factor-κB in the rabbit spinal cord following ischemia and reperfusion (1998) (22)
- Stroke therapy. (1991) (21)
- Diffusion‐weighted MRI for diagnosis and treatment of ischemic stroke (1997) (20)
- Cell transplant therapy for stroke (2000) (20)
- Renaturation of calcium/calmodulin-dependent protein kinase activity after electrophoretic transfer from sodium dodecyl sulfate-polyacrylamide gels to membranes. (1993) (20)
- Status epilepticus and Epstein-Barr virus encephalopathy. Diagnosis by modern serologic techniques. (1985) (20)
- Reduction of intracerebral hemorrhaging in a rabbit embolic stroke model (1999) (20)
- Incidence of cerebral hemorrhage after antifibrinolytic treatment for embolic stroke in rabbits (1990) (19)
- Statins for Secondary Stroke Prevention in Patients without Known Coronary Heart Disease: The Jury Is Still Out (2004) (19)
- Thermal effects of transcranial near-infrared laser irradiation on rabbit cortex (2013) (19)
- Inter-relationships between spinal cord blood flow, neuronal death and neurological function in rabbit spinal cord ischemia (2002) (18)
- Laser Therapy in Acute Stroke Treatment (2008) (18)
- Clinical Trials of Neuroprotective Therapies (2007) (16)
- Cyproheptadine reduces or prevents ischemic central nervous system damage (1985) (16)
- Continuous intrathecal fluid infusions elevate nerve growth factor levels and prevent functional deficits after spinal cord ischemia (2000) (15)
- Medico-Legal Aspects of Using Tissue Plasminogen Activator in Acute Ischemic Stroke (2011) (15)
- Dose-finding study of phototherapy on stroke outcome in a rabbit model of ischemic stroke (2016) (14)
- They Are Relevant to Human Disease (2005) (14)
- Hemodilution with low-molecular-weight hydroxyethyl starch after experimental focal cerebral ischemia in rabbits. (1988) (14)
- The effect of ischemia on biogenic amine concentrations in the central nervous system. (1983) (13)
- Sex Differences in Antiplatelet Response in Ischemic Stroke (2011) (12)
- Effects of intrathecal administration of a cell permeant caspase inhibitor, boc-d-fluoromethylketone (BDFMK), on behavioral deficits following spinal cord ischemia: a dose–response analysis (2003) (12)
- Reversible ischemia increases levels of Alzheimer amyloid protein precursor without increasing levels of mRNA in the rabbit spinal cord. (1997) (12)
- Dehydroepiandrosterone Sulfate Is Neuroprotective in a Reversible Spinal Cord Ischemia Model : Possible Involvement of GABAA Receptors Editorial Comment: Possible Involvement of GABAA Receptors (2000) (12)
- Spinal cord ischemia reduces calcium/calmodulin-dependent protein kinase activity (1991) (12)
- Combination treatment for acute ischemic stroke: A ray of Hope? (1999) (12)
- Proceedings: Estimates of catecholamine turnover rates in individual hypothalamic nuclei of the rat by use of alpha-methyl-para-tyrosine. (1975) (11)
- Lateral cervical puncture (1978) (10)
- Studies of the influence of biogenic amines on central nervous system ischemia. (1986) (10)
- Recent advances in stroke therapy. (1998) (10)
- Analysis of one-component saturable systems such as ligand binding, enzyme kinetic, uptake, and transport data. (1986) (10)
- Perfusion-weighted imaging/diffusion-weighted imaging mismatch on MRI can now be used to select patients for recombinant tissue plasminogen activator beyond 3 hours: con. (2005) (10)
- Quantitative localization of tyrosine hydroxylase, dopamine-β-hydroxylase, phenolethanolamine-N-methyl transferase, and glutamic acid decar☐ylase in spinal cord (1976) (9)
- Prosaptide exacerbates ischemia-induced behavioral deficits in vivo; an effect that does not involve mitogen-activated protein kinase activation (2000) (9)
- Current Status of New Drug Development for Ischemic Stroke (1997) (8)
- Ethical standards in phase 1 trials of neuroprotective agents for stroke therapy. (1998) (8)
- Comprar tPA for Stroke The Story of a Controversial Drug | Justin A. Zivin | 9780195393927 | Oxford University Press (2010) (8)
- Incremental treatments with laser therapy augments good behavioral outcome in the rabbit small clot embolic stroke model (2013) (8)
- Ethics in Clinical Trials (1998) (8)
- Prediction of major vascular events after stroke: the stroke prevention by aggressive reduction in cholesterol levels trial. (2014) (7)
- Activation of nuclear factor-kappaB in the rabbit spinal cord following ischemia and reperfusion. (1998) (7)
- Response to ethical challenges in stroke research (1998) (7)
- 415 – Hemorrhagic Cerebrovascular Disease (2012) (6)
- Neuroprotective Therapies In Stroke (2012) (5)
- Comparison of naloxone and a delta-selective antagonist in experimental spinal stroke. (1983) (5)
- 413 – Approach to Cerebrovascular Diseases (2012) (4)
- Antiplatelet Loading Improves Behavioral Outcome in a Rabbit Model of Stroke (2013) (4)
- Identifying low-quality preclinical studies. (2008) (3)
- A rapid non-operative technique for producing spinal cord injury in animals. (1976) (3)
- Abstract 2173: Effect of High-dose Atorvastatin on Changes in Renal Function: A Secondary Analysis of the Stroke Prevention by Aggressive Reduction of Cholesterol Levels (SPARCL) Trial (2007) (3)
- Animal Models of Ischemia (1992) (3)
- ADVERSE EFFECTS OF SOME ANESTHETICS ON SPINAL CORD ISCHEMIC INJURY (1982) (3)
- ANESTHESIA PROTECTS AGAINST SPINAL CORD INJURY IN TI-E RAT (1987) (2)
- Glutamate Antagonist Therapy Reduces Ischemic Damage (1987) (2)
- The lack of effect of flunarizine on preserving neurologic function after experimental stroke (1990) (2)
- Emerging Treatments for Stroke (1997) (2)
- PREDICTABILITY OF THE CHANGE IN PLASMA NOREPINEPHRINE CONCENTRATION IN ONE VASCULAR BED KNOWING THE CHANGE IN PLASMA NOREPINEPHRINE IN ANOTHER VASCULAR BED (1979) (2)
- 12 – Molecular Mechanisms of Ischemic Brain Disease (2007) (2)
- Safety of tPA + Transcranial Emission of Low-Energy Lasers for Acute Stroke Recovery - Results (P4.219) (2014) (2)
- PO23-781 ATORVASTATIN REDUCES RISK OF STROKE, CARDIAC EVENTS AND ENDARTERECTOMY IN PATIENTS WITH CAROTID STENOSIS: A SUBSTUDY OF SPARCL (2007) (2)
- Delayed Therapy ofExperimental Ischemia WithCompetitive N-Methyl-D-Aspartate Antagonists inRabbits (1993) (2)
- Scaling up from animal to human studies. (2009) (1)
- Excitotoxins and Free Radicals (1999) (1)
- models of embolic stroke and peripheral bleeding A long-half-life and fibrin-specific form of tissue plasminogen activator in rabbit (2011) (1)
- THE EFFECT OF HYPERGLYCEMIA ON NEUROLOGIC OUTCOME FOLLOWING SPINAL CORD ISCHEMIA IN THE RABBIT (1987) (1)
- Methodology of acute trials in stroke. (2009) (1)
- Cerebrovascular Diseases (1996) (1)
- Intra-arterial versus intravenous tissue-type plasminogen activator treatment in experimental stroke. (1994) (1)
- rLOAD: does sex mediate the effect of acute antiplatelet loading on stroke outcome (2014) (1)
- Motor fibers in the sural nerve (2004) (1)
- 30 An open multicenter study of the safety and efficacy of various doses of rt-PA in acute stroke: Interim results (1988) (1)
- Thrombolytic therapy in acute ischemic stroke. (1997) (1)
- 29 – BIOCHEMICAL EVIDENCE FOR A NEUROTRANSMITTER ROLE FOR EPINEPHRINE IN BRAIN STEM AND SPINAL CORD (1977) (1)
- Cerebrovascular Disease: Basic research and stroke therapeutics: what have we learned? (2002) (0)
- Why Are So Few Acute Stroke Patients Receiving Tissue Plasminogen Activator Therapy (2006) (0)
- Trial or Transient Ischemic Attack : The Stroke Prevention by Aggressive Reduction in Effects of Intense Low-Density Lipoprotein Cholesterol Reduction in Patients With Stroke (2007) (0)
- Too Soon to Say (1990) (0)
- Combined Neuroprotection/Thrombolysis in Acute Stroke (1998) (0)
- Translational Challenges: From Animal to Human Experimentation (2003) (0)
- Book Review Cerebrovascular Disease: Pathophysiology, diagnosis, and management Edited by Myron D. Ginsberg and Julien Bogousslavsky. 2067 pp. in two volumes, illustrated. Boston, Blackwell Science, 1998. $495. 0-86542-425-X (1998) (0)
- Protein kinase C is translocated to the plasma membrane during cerebral ischemia, but is partially inactivated (1989) (0)
- Editorial Board (1991) (0)
- Serotonin Antagonists Reduce Central Nervous System Ischemic Damage (1988) (0)
- Intravenous NGF Reduces Thrombus Burden and Lesion-size in Experimental Acute Ischemic Stroke (2007) (0)
- Methysergide therapy in human stroke (1984) (0)
- Detection of Protein Kinase Activity after Renaturation of Proteins Transferred from Sodium Dodecyl Sulfate–Polyacrylamide Gels to Membranes (1994) (0)
- The Impact of Medical Legal Issues on Stroke Treatment (2008) (0)
- Telemedicine System Prospective reliability of the STRokE DOC Wireless / Site Independent (2005) (0)
- Acute Medical Management of Ischemic/Hemorrhagic Stroke (2011) (0)
- Editorial Board (2007) (0)
- Can PWCT in Acute Stroke Predict Outcome After Thrombolytic Therapy (2001) (0)
- The Results of NEST-2: A Double-Blind, Randomized, Phase III Study Evaluating the Safety and Efficacy of Transcranial Laser Therapy for Acute Ischemic Stroke within 24 Hours of Stroke Onset (2009) (0)
- Guidelines on Antithrombotic and Thrombolytic Therapy for Stroke (2005) (0)
- Therapeutic Potential of Leukocyte Antiadhesion Strategies in CNS Ischemia (1998) (0)
- NEUROPATHOLOGY OBSERVATIONS ON THE RABBIT SPINAL CORD FOLLOWING TEMPORARY AND FOCAL ISCHEMIA. II. TEMPORAL PROFILE OF LESION (1980) (0)
- Ischemic Stroke; Acute Treatment (2014) (0)
- Clinical End Points for Stroke Trials (2000) (0)
- Abstract 8734: Loading of Aspirin and Clopidogrel: Effect of Dose on Stroke Outcome in the Rabbit Small Clot Embolic Model (2010) (0)
- NEUROPATHOLOGIC OBSERVATIONS ON THE RABBIT SPINAL CORD FOLLOWING TEMPORARY AND FOCAL ISCHEMIA. I. LIGHT MICROSCOPY: 27 (1979) (0)
- Ximelagatran Is as Effective as Warfarin, but Watch Liver Enzymes (2004) (0)
- Tratamiento del accidente cerebrovascular (1991) (0)
- Chapter 15 Emerging Therapies for Ischemic Stroke (2004) (0)
- Nonstroke Treatment—Reply (2006) (0)
- rLOAD: does sex mediate the effect of acute antiplatelet loading on stroke outcome (2014) (0)
- Nonstroke Treatment: Reply (Letter to the Editor) (2006) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Justin A. Zivin?
Justin A. Zivin is affiliated with the following schools:
